ASHLEY AYLWARD BADGLEY: Open Payments
NPI 1952738387 · CHEYENNE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 23 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $343 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $192 |
| GENZYME CORPORATION | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 3 | $53 |
| Lilly USA, LLC | 3 | $51 |
| ABBVIE INC. | 2 | $31 |
| Janssen Biotech, Inc. | 1 | $17 |
| Galderma Laboratories, L.P. | 1 | $16 |
| BioWound Solutions, Inc. | 1 | $4 |
Products named: DUPIXENT, COSENTYX, TALTZ, SKYRIZI, TREMFYA, NEMLUVIO, Rhapsido, bio-ConneKt.
Industry payments across WY — which companies pay providers there.
